3,098
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment

, , , &
Pages 1001-1010 | Received 14 Jul 2020, Accepted 02 Sep 2020, Published online: 24 Sep 2020